InvestorsHub Logo
Followers 165
Posts 12947
Boards Moderated 1
Alias Born 01/26/2016

Re: Maverick0408 post# 654192

Friday, 12/08/2023 12:45:12 PM

Friday, December 08, 2023 12:45:12 PM

Post# of 703739
Maverick0408,

Maybe, just maybe a bigger company heard about what a smaller company was working on and wanted in on the action or was directed to it. Gee, has that ever happened before?; ). Hint, think Cognate expansion plans after NWBO had access to data which CRL was advised about from a former associate employee of NWBO. Hmmm. Maybe going BIG really means going REALLY BIG!; ). Since NWBO developed it all in house the ownership belongs to NWBO shareholders without being diluted by some big pharma interest that was not going to be incentivized to develop a partner/competitor that might cause a reduction in the use of some of their products with any sense of urgency. Think about rGBM patients and 50% survival vs 65% with checkpoint inhibitor. Not all patients benefit from temodar and checkpoint inhibitors. Personalized treatment is coming and SOC will be changed to reflect this. Best wishes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News